BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19719773)

  • 1. Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells.
    Hanyu A; Kojima K; Hatake K; Nomura K; Murayama H; Ishikawa Y; Miyata S; Ushijima M; Matsuura M; Ogata E; Miyazawa K; Imamura T
    Cancer Sci; 2009 Nov; 100(11):2085-92. PubMed ID: 19719773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model.
    Mori A; Arii S; Furutani M; Hanaki K; Takeda Y; Moriga T; Kondo Y; Gorrin Rivas MJ; Imamura M
    Int J Cancer; 1999 Mar; 80(5):738-43. PubMed ID: 10048976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.
    Asano M; Yukita A; Matsumoto T; Kondo S; Suzuki H
    Cancer Res; 1995 Nov; 55(22):5296-301. PubMed ID: 7585591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiogenesis, tumour growth and experimental metastasis of human fibrosarcoma cells HT1080 by a multimeric form of the laminin sequence Tyr-Ile-Gly-Ser-Arg (YIGSR).
    Iwamoto Y; Nomizu M; Yamada Y; Ito Y; Tanaka K; Sugioka Y
    Br J Cancer; 1996 Mar; 73(5):589-95. PubMed ID: 8605091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin.
    Kou G; Shi J; Chen L; Zhang D; Hou S; Zhao L; Fang C; Zheng L; Zhang X; Liang P; Zhang X; Li B; Guo Y
    Cancer Lett; 2010 Dec; 299(2):130-6. PubMed ID: 20826049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MULTIMERIN2 binds VEGF-A primarily via the carbohydrate chains exerting an angiostatic function and impairing tumor growth.
    Colladel R; Pellicani R; Andreuzzi E; Paulitti A; Tarticchio G; Todaro F; Colombatti A; Mongiat M
    Oncotarget; 2016 Jan; 7(2):2022-37. PubMed ID: 26655500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis.
    Shimo T; Nakanishi T; Nishida T; Asano M; Sasaki A; Kanyama M; Kuboki T; Matsumura T; Takigawa M
    Oncology; 2001; 61(4):315-22. PubMed ID: 11721179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases.
    Rad FH; Le Buanec H; Paturance S; Larcier P; Genne P; Ryffel B; Bensussan A; Bizzini B; Gallo RC; Zagury D; Uzan G
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2837-42. PubMed ID: 17301234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.
    Collingridge DR; Carroll VA; Glaser M; Aboagye EO; Osman S; Hutchinson OC; Barthel H; Luthra SK; Brady F; Bicknell R; Price P; Harris AL
    Cancer Res; 2002 Oct; 62(20):5912-9. PubMed ID: 12384557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts.
    Miyazaki S; Kikuchi H; Iino I; Uehara T; Setoguchi T; Fujita T; Hiramatsu Y; Ohta M; Kamiya K; Kitagawa K; Kitagawa M; Baba S; Konno H
    Int J Cancer; 2014 Jul; 135(2):295-307. PubMed ID: 24375080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Implication of vascular endothelial growth factor (VEGF) in human head and neck cancer].
    Ueno Y
    Nihon Jibiinkoka Gakkai Kaiho; 2006 Mar; 109(3):163-70. PubMed ID: 16615431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor (NGF) has an anti-tumor effects through perivascular innervation of neovessels in HT1080 fibrosarcoma and HepG2 hepatitis tumor in nude mice.
    Kawasaki H; Goda M; Fukuhara S; Hashikawa-Hobara N; Zamami Y; Takatori S
    J Pharmacol Sci; 2019 May; 140(1):1-7. PubMed ID: 31178329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60.
    Yang J; Wang Q; Qiao C; Lin Z; Li X; Huang Y; Zhou T; Li Y; Shen B; Lv M; Feng J
    Cell Mol Immunol; 2014 May; 11(3):285-93. PubMed ID: 24608894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts.
    Roland CL; Dineen SP; Lynn KD; Sullivan LA; Dellinger MT; Sadegh L; Sullivan JP; Shames DS; Brekken RA
    Mol Cancer Ther; 2009 Jul; 8(7):1761-71. PubMed ID: 19567820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
    Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
    Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
    Wang F; Tian YH; Li L; Chen XF; Hu HH; Li CY; Huang Q
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):165-70. PubMed ID: 12006990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo.
    Borgström P; Bourdon MA; Hillan KJ; Sriramarao P; Ferrara N
    Prostate; 1998 Apr; 35(1):1-10. PubMed ID: 9537593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-color imaging of angiogenesis and its inhibition in bone and soft tissue sarcoma.
    Hayashi K; Yamauchi K; Yamamoto N; Tsuchiya H; Tomita K; Amoh Y; Hoffman RM; Bouvet M
    J Surg Res; 2007 Jun; 140(2):165-70. PubMed ID: 17418866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.